Search

Search Constraints

You searched for: Author/Creator Burchert, Andreas

Search Results

1. Addition of sorafenib versus placebo to standard therapy in patients aged 60 years or younger with newly diagnosed acute myeloid leukaemia (SORAML): a multicentre, phase 2, randomised controlled trial. Issue 16 (December 2015)

2. Assessment of Early Therapy Response of Non‐Hodgkin's and Hodgkin's Lymphoma Using B‐Mode Ultrasound and Dynamic Contrast‐Enhanced Ultrasound. (30th November 2021)

3. Decitabine treatment in 311 patients with acute myeloid leukemia: outcome and impact of TP53 mutations – a registry based analysis. Issue 6 (12th May 2021)

4. High β-1, 4-Galactosyltransferase-I expression in peripheral T-lymphocytes is associated with a low risk of relapse in germ-cell cancer patients receiving high-dose chemotherapy with autologous stem cell reinfusion. (4th May 2018)

6. Long-term efficacy of reduced-intensity versus myeloablative conditioning before allogeneic haemopoietic cell transplantation in patients with acute myeloid leukaemia in first complete remission: retrospective follow-up of an open-label, randomised phase 3 trial. Issue 4 (April 2018)

7. Outcome of non-mold effective anti-fungal prophylaxis in patients at high-risk for invasive fungal infections after allogenic stem cell transplantation. Issue 8 (3rd July 2019)

9. Response to tyrosine kinase inhibitors in myeloid neoplasms associated with PCM1‐JAK2, BCR‐JAK2 and ETV6‐ABL1 fusion genes. Issue 7 (28th April 2020)

10. Sorafenib induces paradoxical phosphorylation of the extracellular signal-regulated kinase pathway in acute myeloid leukemia cells lacking FLT3-ITD mutation. Issue 9 (2nd September 2015)